(210) | Number of the EPO application | 17804374 |
(220) | Filing date of the EPO application | 2017.11.07 |
(80) | EPO patent specification publication (B) | EPB nr. 09/2024, 2024.02.28 |
(110) | EPO patent number | 3538096 |
(21) | Number of the application | e 2019 1041 |
(71) | Name(s) of applicant(s), code of the country | Tisento Therapeutics Inc., US; |
(72) | Name(s) of inventor(s), code of the country | JUNG Joon, US; LEE Thomas Wai-Ho, US; IYENGAR Rajesh R., US; PERL Nicholas Robert, US; GERMANO Peter, US; RIBADENEIRA Maria D., US; TANG Kim, US; |
(73) | Name(s) of owner(s), code of the country | Tisento Therapeutics Inc., US; |
(54) | Title of the invention | TREATMENT OF CNS DISEASES WITH SGC STIMULATORS |
(13) | Kind-of-document code | A1 |
(51) | International Patent Classification | A61K 31/437 (2006.01.01); A61K 31/5025 (2006.01.01); A61K 31/506 (2006.01.01); A61K 31/519 (2006.01.01); A61P 25/00 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2019.10.31 |
(30) | Priority | 201662419059 P, 2016.11.08, US |
(86) | International application | PCT/US2017/060299, 2017.11.07 |
(87) | International publication | WO 2018/089328, 2018.05.17 |